Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Stocks rose Thursday as investors responded to a flurry of quarterly earnings reports from major companies and better-than-expected retail sales data.

The Carney government’s new focus on military spending presents an opportunity for Canadian industries to secure major new ...

At the Global First Partners Academy, the wives of world leaders get a rare chance to connect and compare notes.

The annual amount of water AI is on pace to use by 2027 could serve the entire population of Canada for more than a year.

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.